Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants

CompletedOBSERVATIONAL
Enrollment

1,166

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

December 31, 2016

Conditions
Venous ThromboembolismAtrial Fibrillation
Interventions
OTHER

complications and compliance with GIHP recommendations

Description of complications, compliance, major bleeding events, treatments, reversal strategies.

Trial Locations (41)

38043

CHU de Grenoble, Grenoble

Unknown

CHU Brugmann, Brussels

Hôpitaux du Léman, Thonon-les-Bains

CH Agen, Agen

CHU d'Amiens, Amiens

CHR Annecy, Annecy

CHU Besançon, Besançon

CHU Bordeaux, Bordeaux

CH Castres, Castres

CH Chambéry, Chambéry

CHU Clermont-Ferrand, Clermont-Ferrand

CH Alpes leman, Contamine-sur-Arve

CHU Dijon, Dijon

CH Gap, Gap

Groupe Hospitalier Mutualiste Grenoble, Grenoble

CHRU Lille, Lille

HCL - Edouard Herriot, Lyon

HCL - Hôpital de la Croix-Rousse, Lyon

HCL - Lyon Sud, Lyon

CHU Marseille, Marseille

CHU Montpellier, Montpellier

Centre Emile Gallé - SINCAL, Nancy

CHU Nancy, Nancy

CHU Nantes, Nantes

CH de Niort, Niort

CHU Nimes, Nîmes

APHP - Antoine Beclere, Paris

APHP - Tenon, Paris

APHP Henri Mondor, Paris

APHP Hôpital Bichat, Paris

APHP Hôpital Cochin, Paris

APHP Site St Antoine, Paris

Aphp-Hegp, Paris

APHP-Hôpital Beaujon, Paris

Centre Hôpital Américain, Paris

CHU Bicêtre, Paris

CHU Rennes, Rennes

CHRU Strasbourg - Hôpital Civil, Strasbourg

Hôpital d'Instruction des Armées Sainte-Anne, Toulon

CHU Toulouse, Toulouse

CH Voiron, Voiron

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Floralis

INDUSTRY

lead

University Hospital, Grenoble

OTHER

NCT02185027 - Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants | Biotech Hunter | Biotech Hunter